Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed May 13, 2021 · 10-Q · 43 days after period end · 0001564590-21-027601
| Metric | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|
| Revenue | $952.00K | — | — |
| Net Income | -$42.18M | -$24.89M | -$14.18M |
| EPS Diluted | -$0.47 | -$5.99 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 13, 2021 · 43 d after period end
